Dashboard
Manage Tickers

RPRXRoyalty Pharma plc

Nasdaq royaltypharma.com


$ 26.92 $ -0.28 (-1.03 %)    

Friday, 14-Jun-2024 15:59:49 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 479.30 $ 2.47 (0.52 %)
DIA $ 386.46 $ -0.42 (-0.11 %)
SPY $ 542.65 $ 0.33 (0.06 %)
TLT $ 94.67 $ 0.79 (0.84 %)
GLD $ 215.76 $ 2.76 (1.3 %)
$ 26.92
$ 27.03
$ 0.00 x 0
$ 26.94 x 100
$ 26.70 - $ 27.16
$ 25.35 - $ 31.44
1,907,850
na
16.08B
$ 0.63
$ 20.13
TBD
na
na ($ 0.03)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-09-2024 03-31-2024 10-Q
2 02-15-2024 12-31-2023 10-K
3 11-08-2023 09-30-2023 10-Q
4 08-08-2023 06-30-2023 10-Q
5 05-09-2023 03-31-2023 10-Q
6 02-15-2023 12-31-2022 10-K
7 11-08-2022 09-30-2022 10-Q
8 08-04-2022 06-30-2022 10-Q
9 05-05-2022 03-31-2022 10-Q
10 02-15-2022 12-31-2021 10-K
11 11-10-2021 09-30-2021 10-Q
12 08-11-2021 06-30-2021 10-Q
13 05-11-2021 03-31-2021 10-Q
14 02-24-2021 12-31-2020 10-K
15 11-12-2020 09-30-2020 10-Q
16 08-12-2020 06-30-2020 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

wall-streets-most-accurate-analysts-spotlight-on-3-health-care-stocks-delivering-high-dividend-yields
Wall Street's Most Accurate Analysts Spotl...
06/12/2024 13:15:52

royalty-pharma-prices-offering-of-15b-of-senior-unsecured-notes
Royalty Pharma Prices Offering Of $1.5B Of...
06/03/2024 21:18:40

The offering is expected to close on June 10, 2024. Royalty Pharma intends to use the net proceeds from the Notes for general c...

ubs-downgrades-royalty-pharma-to-neutral-announces-28-price-target
UBS Downgrades Royalty Pharma to Neutral, ...
06/03/2024 15:50:14

UBS analyst Ashwani Verma downgrades Royalty Pharma (NASDAQ:RPRX) from Buy to Neutral and announces $28 price target.

why-is-agios-pharmaceuticals-stock-trading-higher-on-tuesday
Why Is Agios Pharmaceuticals Stock Trading...
05/28/2024 17:00:41

Agios Pharmaceuticals sells its 15% royalty rights on U.S. net sales of Servier's vorasidenib to Royalty Pharma for $905 mi...

Core News & Articles
Royalty Pharma Acquires Interest In Agios ...
05/28/2024 11:17:29

heart-disease-focused-cytokinetics-operations-are-on-track-despite-acquisition-uncertainty-analysts-observe
Heart Disease-Focused Cytokinetics Operati...
05/23/2024 18:30:40

Unlock the latest on Royalty Pharma plc & Cytokinetics Inc.'s strategic funding collaboration for aficamten's comme...

Core News & Articles
Cytokinetics And Royalty Pharma Enter Fund...
05/22/2024 20:02:52

Core News & Articles
Royalty Pharma To Acquire Royalties And Mi...
05/09/2024 11:20:42

Under the terms of ImmuNext's licensing agreement with Sanofi, ImmuNext is entitled to receive an upward tiering net royalt...

royalty-pharma-sees-fy24-portfolio-receipts-of-26b---27b
Royalty Pharma Sees FY24 Portfolio Receipt...
05/09/2024 11:05:34

royalty-pharma-q1-sales-56800m-miss-66322m-estimate
Royalty Pharma Q1 Sales $568.00M Miss $663...
05/09/2024 11:02:34

Royalty Pharma (NASDAQ:RPRX) reported quarterly sales of $568.00 million which missed the analyst consensus estimate of $663.22...

amgen-reports-better-than-expected-q1-results-50m-milestone-payment
Amgen Reports Better-Than-Expected Q1 Resu...
05/02/2024 21:44:40

Amgen reported quarterly earnings of $3.96 per share which beat the analyst consensus estimate of $3.87 by 2.33%. The company s...

Core News & Articles
Arrowhead Pharmaceuticals Earns $50M Miles...
05/02/2024 20:39:45

Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) today announced a $50 million milestone payment was received from Royalty Pharma ...

b-of-a-securities-maintains-buy-on-royalty-pharma-lowers-price-target-to-38
B of A Securities Maintains Buy on Royalty...
04/12/2024 12:01:57

B of A Securities analyst Geoff Meacham maintains Royalty Pharma (NASDAQ:RPRX) with a Buy and lowers the price target from $...

looking-into-royalty-pharmas-recent-short-interest
Looking Into Royalty Pharma's Recent Short...
04/04/2024 15:15:24

royalty-pharma-q4-sales-59600m-miss-67365m-estimate-net-income-attributable-to-royalty-pharma-494m-versus-loss-of-456m-year-ago
Royalty Pharma Q4 Sales $596.00M Miss $673...
02/15/2024 12:34:58

Royalty Pharma (NASDAQ:RPRX) reported quarterly sales of $596.00 million which missed the analyst consensus estimate of $673.65...

earnings-scheduled-for-february-15-2024
Earnings Scheduled For February 15, 2024
02/15/2024 10:17:01

Companies Reporting Before The Bell • Cognex (NASDAQ:CGNX) is estimated to report quarterly earnings at $0.10 per share on rev...

royalty-pharmas-earnings-a-preview
Royalty Pharma's Earnings: A Preview
02/14/2024 14:00:50

correction-royalty-pharma-announces-quarterly-dividend-increase-from-020-to-021
CORRECTION: Royalty Pharma Announces Quart...
01/19/2024 13:23:03

royalty-pharma-announces-quarterly-dividend-increase-from-020-to-021
Royalty Pharma Announces Quarterly Dividen...
01/19/2024 13:16:54

Reflecting a 5% increase in the company's quarterly dividend over the previous quarter's dividend. Reflecting a 5% incr...

Core News & Articles
Watching MSCI Inc.; Spruce Point Capital M...
01/17/2024 14:39:41

NOTE TO EDITORS: The Following is an Investment Opinion Issued by Spruce Point Capital ManagementProvides Evidence That Each of...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

06/28/2024 Malibu Boats, Inc. (MBUU)
07/01/2024 Globe Life Inc. f/k/a Torchmark Corporation (GL)
07/01/2024 Equinix, Inc. (EQIX)
07/02/2024 Intel Corporation (INTC)
07/05/2024 AXT, Inc. (AXTI)
07/05/2024 Altimmune, Inc. (ALT)
07/09/2024 Li Auto Inc. (LI)
07/12/2024 Inari Medical, Inc. (NARI)
07/12/2024 Sprout Social, Inc. (SPT)
07/15/2024 UnitedHealth Group Inc. (UNH)

NEW CASE INVESTIGATION

AnaptysBio Inc (ANAB)